Skip to main content
Top
Published in: Rheumatology International 1/2024

Open Access 13-12-2023 | Ehlers-Danlos Syndrome | Systematic Review

Psychological interventions to improve pain, fatigue, anxiety, depression, and quality of life in children and adults with hypermobility spectrum disorders and Ehlers-Danlos syndrome: a systematic review

Authors: Natalie L. Clark, Gurvinder Singh Kainth, Melissa Johnson, Amar Rangan, Lucksy Kottam, Katherine Swainston

Published in: Rheumatology International | Issue 1/2024

Login to get access

Abstract

Hypermobility spectrum disorders (HSD) affect individuals across physical, psychological and social domains, making assessment and management difficult. Management for this condition primarily focuses on addressing the musculoskeletal complaints using physiotherapy rather than the additional manifestations such as fatigue, anxiety and depression. This systematic review aims to identify psychological interventions and assess whether they improve the lived experiences of individuals with HSD. It also aims to assess which psychological interventions were most effective, which symptoms were most effectively managed by a psychological intervention, and whether there were differences between children and adults. Studies were included if they were a randomised controlled trial or pre/post-test design, a sample of any age and clinical diagnosis of HSD (including Ehlers-Danlos syndrome), used a psychological intervention and assessed the effect of the intervention on lived experiences using appropriate outcome measures. Risk of bias was assessed using the Mixed Methods Appraisal Tool. The results were narratively synthesised. Six studies were included in the review, one isolated psychological intervention and five incorporated a psychological intervention within a multidisciplinary programme. The interventions predominantly aimed to reduce pain including intensity, interference, pain-related fear and catastrophising, with anxiety and depression, affect, daily living, fatigue also being evaluated. The most beneficial psychological interventions were those delivered alongside physiotherapy in an outpatient or community setting, improving both the physical and psychological aspects of pain, subsequently improving quality of life. However, there lacks randomised controlled trials with larger samples to definitively confirm the significant findings discussed in this review.
Literature
6.
go back to reference Clark CJ, Khattab AD, Carr ECJ (2014) Chronic widespread pain and neurophysiological symptoms in joint hypermobility syndrome (JHS). Int J Ther Rehabil 21:60–67CrossRef Clark CJ, Khattab AD, Carr ECJ (2014) Chronic widespread pain and neurophysiological symptoms in joint hypermobility syndrome (JHS). Int J Ther Rehabil 21:60–67CrossRef
8.
go back to reference Wasim S, Suddaby JS, Parikh M, Leylachian S, Ho B, Guerin A, So J (2019) Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study. Rheumatol Int 39:1241–1248. https://doi.org/10.1007/s00296-019-04293-wCrossRefPubMed Wasim S, Suddaby JS, Parikh M, Leylachian S, Ho B, Guerin A, So J (2019) Pain and gastrointestinal dysfunction are significant associations with psychiatric disorders in patients with Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective study. Rheumatol Int 39:1241–1248. https://​doi.​org/​10.​1007/​s00296-019-04293-wCrossRefPubMed
13.
go back to reference Johnson M, Kottam L, Rangan A (2022) Exploring the experiences of diagnosis and physiotherapy management in patients with hypermobility spectrum disorders and shoulder instability: a focus group report. Physiotherapy Pain Association 52:20–25 Johnson M, Kottam L, Rangan A (2022) Exploring the experiences of diagnosis and physiotherapy management in patients with hypermobility spectrum disorders and shoulder instability: a focus group report. Physiotherapy Pain Association 52:20–25
15.
go back to reference Song B, Yeh P, Nguyen D, Ikpeama U, Epstein M, Harrell J (2020) Ehlers-Danlos syndrome: an analysis of the current treatment options. Pain Physician 23:429–428CrossRefPubMed Song B, Yeh P, Nguyen D, Ikpeama U, Epstein M, Harrell J (2020) Ehlers-Danlos syndrome: an analysis of the current treatment options. Pain Physician 23:429–428CrossRefPubMed
20.
21.
go back to reference Chaleat-Valayer E, Amelie Z, Marie-Helene B, Perretant I, Monique B, Pauline O, Sandrine T (2019) Therapeutic education programme for patients with hypermobile Ehlers-Danlos syndrome: feasibility and satisfaction of the participants. Educ Therapeut Pat Therap Pat Educ 1:1–14. https://doi.org/10.1051/tpe/2019002CrossRef Chaleat-Valayer E, Amelie Z, Marie-Helene B, Perretant I, Monique B, Pauline O, Sandrine T (2019) Therapeutic education programme for patients with hypermobile Ehlers-Danlos syndrome: feasibility and satisfaction of the participants. Educ Therapeut Pat Therap Pat Educ 1:1–14. https://​doi.​org/​10.​1051/​tpe/​2019002CrossRef
26.
go back to reference Hong QN, Fabregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon MP, Griffiths F, Nicolau B, O’Cathain A, Rousseau MC, Vedel I, Pluye P (2018) The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Edu Inf 34:285–291. https://doi.org/10.3233/EFI-180221CrossRef Hong QN, Fabregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon MP, Griffiths F, Nicolau B, O’Cathain A, Rousseau MC, Vedel I, Pluye P (2018) The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Edu Inf 34:285–291. https://​doi.​org/​10.​3233/​EFI-180221CrossRef
30.
go back to reference Cleeland CS (1989) Measurement of pain by subjective report. In: Chapman CR, Loeser JD (eds) Advances in Pain Research and Therapy. Raven, New York, pp 391–403 Cleeland CS (1989) Measurement of pain by subjective report. In: Chapman CR, Loeser JD (eds) Advances in Pain Research and Therapy. Raven, New York, pp 391–403
36.
go back to reference Sullivan MJL, Bishop SR, Pivik J (1995) The Pain Catastrophizing Scale: development and validation. Psychol Assess 7:524–532CrossRef Sullivan MJL, Bishop SR, Pivik J (1995) The Pain Catastrophizing Scale: development and validation. Psychol Assess 7:524–532CrossRef
39.
go back to reference Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 54:1063–1070CrossRefPubMed Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 54:1063–1070CrossRefPubMed
41.
go back to reference Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233CrossRefPubMed Ware JE, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233CrossRefPubMed
Metadata
Title
Psychological interventions to improve pain, fatigue, anxiety, depression, and quality of life in children and adults with hypermobility spectrum disorders and Ehlers-Danlos syndrome: a systematic review
Authors
Natalie L. Clark
Gurvinder Singh Kainth
Melissa Johnson
Amar Rangan
Lucksy Kottam
Katherine Swainston
Publication date
13-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 1/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05503-2

Other articles of this Issue 1/2024

Rheumatology International 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.